|
|
|
|
|
-
Thursday, February 12, 2026
|
|
|
|
|
| Press Releases |
|
 |
|
|
|
|
|
|
 |
| Latest Press Releases |
|
GTJAI Sponsored Axera's Listing on the Main Board of HKEX
Feb 11, 2026 19:40 HKT/SGT
|
|
|
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
Feb 11, 2026 19:00 HKT/SGT
|
|
|
Focus Graphite Engages Dr. Reuter Investor Relations to Expand German and European Capital Markets Presence
Feb 11, 2026 18:29 HKT/SGT
|
|
|
CleverTap Recognized as a Leader in Latest Gartner Magic Quadrant for Personalization Engines
Feb 11, 2026 14:30 HKT/SGT
|
|
|
Premiere of Three-Row Highlander BEV in North America
Feb 11, 2026 14:25 JST
|
|
|
The 18th Annual Global CSR & ESG Summit & Awards 2026 Arrives in Bangkok -- Igniting Asia with AI, Energy & ESG Innovation on 23 April 2026
Feb 11, 2026 11:39 HKT/SGT
|
|
|
U.S. Marine Corps Selects GA-ASI for MUX TACAIR Collaborative Combat Aircraft Program
Feb 11, 2026 08:00 HKT/SGT
|
|
|
Changing Your Dog's Diet May Help the Planet More Than Changing Your Own, Study Finds
Feb 11, 2026 07:00 HKT/SGT
|
|
|
Kincora and AngloGold Ashanti Exploration Expands and Upgrades Nevertire with Drilling Recommenced
Feb 10, 2026 19:29 HKT/SGT
|
|
|
EssexBio Bolsters Commitment to Ophthalmology Innovation at APAO 2026 in Hong Kong
Feb 10, 2026 18:14 HKT/SGT
|
|
|
Honda Works Partner Aston Martin Aramco Formula One(TM) Team Unveils Livery of "AMR26" F1(TM) Machine Equipped with Honda Power Unit Ahead of the 2026 Race Season
Feb 10, 2026 18:25 JST
|
|
|
CTF Life+ Announces Winners of Financial Empowerment Case Competition, Innovative Platform Advances Intergenerational Inclusion
Feb 10, 2026 17:02 HKT/SGT
|
|
|
Honda to Make Organizational Changes to Further Enhance Competitiveness its Motorcycle, Automobile and Power Products Business
Feb 10, 2026 17:53 JST
|
|
|
KS Energy and Hitachi Collaborate on Extra-High Voltage Battery Energy Storage System
Feb 10, 2026 14:15 JST
|
|
|
Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China
Feb 10, 2026 13:34 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
| Copyright © 2026 ACN Newswire - Asia Corporate News Network |
|
|
Connect With us:
|
|
| |
